These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 18814800)
1. [PK/PD breakpoints and clinical/bacteriological effects of cefcapene pivoxil fine granules for children at free drug concentrations in pediatric patients with respiratory infection]. Toyonaga Y; Iwai N; Motohiro T; Sunakawa K; Fujii R Jpn J Antibiot; 2008 Jun; 61(3):172-83. PubMed ID: 18814800 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of 5-day cefcapene-pivoxil and 10-day amoxicillin or cefcapene-pivoxil for treatment of group A streptococcal pharyngitis in children. Sakata H J Infect Chemother; 2008 Jun; 14(3):208-12. PubMed ID: 18574656 [TBL] [Abstract][Full Text] [Related]
3. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field]. Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496 [TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients]. Ishihara R; Ishii Y; Suzuki Y; Nakazawa A; Deguchi K; Toyonaga Y Jpn J Antibiot; 1998 Jan; 51(1):1-10. PubMed ID: 9557272 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections]. Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588 [TBL] [Abstract][Full Text] [Related]
6. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II]. Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics]. Iwai N; Nakamura H; Miyazu M; Watanabe Y Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911 [TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. Nakamura T; Takahashi H Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with laryngopharyngitis and tonsillitis caused by Streptococcus pyogenes]. Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M Jpn J Antibiot; 2010 Aug; 63(4):299-311. PubMed ID: 21298863 [TBL] [Abstract][Full Text] [Related]
10. Comparative clinical study of cefcapene pivoxil and cefteram pivoxil in chronic respiratory tract infections by a double-blind method. Saito A; Hiraga Y; Watanabe A; Saito A; Shimada K; Kobayashi H; Odagiri S; Miki F; Soejima R; Oizumi K; Hara K; Nakashima M; J Int Med Res; 2004; 32(6):590-607. PubMed ID: 15587753 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children]. Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494 [TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections]. Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media]. Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
15. [The clinical usefulness and transference of cefcapene pivoxil (CFPN-PI) into the maternal cubital blood, umbilical blood and amniotic fluid in premature rupture of the membranes]. Narimatsu A; Tamura H Jpn J Antibiot; 2001 Feb; 54(2):95-102. PubMed ID: 11338683 [TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety, and tissue penetration of solithromycin in Japanese patients with otorhinolaryngological infections. Kurono Y; Kudo F; Watanabe A; Yamatake T; Shimada S; Suzuki K Auris Nasus Larynx; 2024 Apr; 51(2):379-390. PubMed ID: 38065757 [TBL] [Abstract][Full Text] [Related]
17. [A clinical study on cefditoren pivoxil granules in the pediatric field]. Mori A; Meguro H; Terashima I; Fujii R Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections]. Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335 [TBL] [Abstract][Full Text] [Related]
19. [Basic and clinical studies on cefditoren pivoxil in pediatric field]. Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207]. Fujii R; Yoshioka H; Okuno A; Fujita K; Murono K; Maruyama S; Sakata H; Iseki K; Wagatsuma Y; Fukushima N Jpn J Antibiot; 1993 Jan; 46(1):95-114. PubMed ID: 8455336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]